E-diary use in clinical headache practice: A prospective observational study
Open Access
- 2 May 2021
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 41 (11-12) , 1161-1171
Abstract
Aim: To determine whether our E-diary can be used to diagnose migraine and provide more reliable migraine-related frequency numbers compared to patients’ self-reported estimates. Methods: We introduced a self-developed E-diary including automated algorithms differentiating headache and migraine days, indicating whether a patient has migraine. Reliability of the E-diary diagnosis in combination with two previously validated E-questionnaires was compared to a physician’s diagnosis as gold standard in headache patients referred to the Leiden Headache Clinic (n = 596). In a subset of patients with migraine (n = 484), self-estimated migraine-related frequencies were compared to diary-based results. Results: The first migraine screening approach including an E-headache questionnaire, and the E-diary revealed a sensitivity of 98% and specificity of 17%. In the second approach, an E-migraine questionnaire was added, resulting in a sensitivity of 79% and specificity of 69%. Mean self-estimated monthly migraine days, non-migrainous headache days and days with acute medication use were different from E-diary-based results (absolute mean difference ± standard deviation respectively 4.7 ± 5.0, 6.2 ± 6.6 and 4.3 ± 4.8). Conclusion: The E-diary including algorithms differentiating headache and migraine days showed usefulness in diagnosing migraine. The use emphasised the need for E-diaries to obtain reliable information, as patients do not reliably recall numbers of migraine days and acute medication intake. Adding E-diaries will be helpful in future headache telemedicine.Keywords
This publication has 17 references indexed in Scilit:
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic MigraineJAMA, 2018
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd editionCephalalgia, 2018
- A Controlled Trial of Erenumab for Episodic MigraineNew England Journal of Medicine, 2017
- Fremanezumab for the Preventive Treatment of Chronic MigraineNew England Journal of Medicine, 2017
- National randomized controlled trial of virtual house calls for Parkinson diseaseNeurology, 2017
- Self-monitoring of health data by patients with a chronic disease: does disease controllability matter?BMC Family Practice, 2017
- Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineursCephalalgia, 2011
- Validity of Self-Reported Menstrual Cycle LengthAnnals of Epidemiology, 2007
- Diaries and Calendars for Migraine. A ReviewCephalalgia, 2006
- The prevalence and characteristics of migraine in a population-based cohortNeurology, 1999